南华生物挂牌售子公司股权，现待定受让方报价近2000万

Core Viewpoint - Nanhua Biomedical Co., Ltd. has approved the sale of its subsidiary Nanhua Heping Hospital Management (Hunan) Co., Ltd. with a highest bid of 19.9919 million yuan [1] Group 1 - The board of Nanhua Biomedical approved the proposal to sell the entire equity of its subsidiary [1] - The highest bid received for the subsidiary is 19.9919 million yuan, which is also the listing price [1] - The process is currently in the stage of soliciting opinions from original shareholders, who have the right of first refusal [1] Group 2 - If the original shareholders waive their right, the highest bidder will become the acquirer; otherwise, the original shareholders will retain ownership [1] - This transaction does not constitute a related party transaction or a major asset restructuring [1] - The company will disclose further developments in a timely manner and remind investors to pay attention to risks [1]